As of May 14, 2026, Vera Therapeutics's top three insider holders are Capital Lp Commodore (TenPercentOwner, 4.40Mn shares), Patrick G Enright (Director, 3.60Mn shares), Venture Partners X, L.P. Sofinnova (TenPercentOwner, 3.47Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Lp Commodore | - | 0 | 4,400,000 | 12 Jan, 2024 |
| Patrick G Enright | - | 0 | 3,596,593 | 25 Jun, 2025 |
| Venture Partners X, L.P. Sofinnova | - | 3,467,156 | 0 | 08 Feb, 2023 |
| Venture Partners X, L.P. Sofinnova | - | 3,467,156 | 0 | 08 Feb, 2023 |
| Venture Partners X, L.P. Sofinnova | - | 3,467,156 | 0 | 08 Feb, 2023 |
| Venture Partners X, L.P. Sofinnova | - | 3,467,156 | 0 | 08 Feb, 2023 |
| Group Inc. Carlyle | - | 0 | 2,960,231 | 19 Aug, 2022 |
| Group Inc. Carlyle | - | 0 | 2,960,231 | 19 Aug, 2022 |
| Maha Katabi | - | 0 | 2,793,987 | 25 Mar, 2024 |
| Beth C Seidenberg | - | 0 | 1,737,383 | 14 Mar, 2023 |
| Capital Partners Iv, Llc Longitude | - | 0 | 1,714,285 | 08 Feb, 2023 |
| Marshall Fordyce | President And Ceo | 235,244 | 0 | 15 Apr, 2026 |
| Beth C Seidenberg | - | 131,553 | 0 | 30 Oct, 2024 |
| Sean Grant | Chief Financial Officer | 114,181 | 0 | 25 Feb, 2026 |
| Joseph R Young | Svp, Finance, Chief Acct Offcr | 75,754 | 0 | 16 Mar, 2026 |
| Joseph R Young | Svp, Finance, Chief Acct Offcr | 75,754 | 0 | 16 Mar, 2026 |
| Laurence Matthew Skelton | Chief Commercial Officer | 64,218 | 0 | 25 Feb, 2026 |
| Robert Brenner | Chief Medical Officer | 50,947 | 0 | 25 Feb, 2026 |
| Jason S Carter | Chief Legal Officer | 49,136 | 0 | 25 Nov, 2025 |
| David Lee Johnson | Chief Operating Officer | 45,727 | 0 | 25 Feb, 2026 |
| William D. Turner | Chief Regulatory Officer | 45,313 | 0 | 25 Feb, 2026 |
| Jane Wright-Mitchell | Chief Legal Officer | 42,403 | 0 | 25 Mar, 2026 |
| Jane Wright-Mitchell | Chief Legal Officer | 42,403 | 0 | 25 Mar, 2026 |
| Joanne Curley | Chief Development Officer | 26,962 | 0 | 23 Aug, 2023 |
| Celia Lin | Chief Medical Officer | 11,010 | 0 | 23 Aug, 2023 |
| Sean Grant | Chief Financial Officer | 0 | 6,233 | 05 Apr, 2024 |
| Patrick G Enright | - | 5,882 | 0 | 15 Dec, 2025 |
| Beth C Seidenberg | - | 0 | 4,012 | 20 Sep, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Apr, 2026 | Marshall Fordyce | Class A Common Stock | D | 14,130 | $43.66 | 244,065 | D | S |
| 14 Apr, 2026 | Marshall Fordyce | Class A Common Stock | D | 7,921 | $44.58 | 236,144 | D | S |
| 14 Apr, 2026 | Marshall Fordyce | Class A Common Stock | D | 900 | $45.51 | 235,244 | D | S |
| 23 Mar, 2026 | Jane Wright-Mitchell | Class A Common Stock | A | 42,403 | $0.00 | 42,403 | D | A |
| 23 Mar, 2026 | Jane Wright-Mitchell | Class A Common Stock | A | 42,403 | $0.00 | 42,403 | D | A |
| 23 Mar, 2026 | Jane Wright-Mitchell | Stock Option (right to buy) | A | 56,850 | $0.00 | 56,850 | D | A |
| 23 Mar, 2026 | Jane Wright-Mitchell | Stock Option (right to buy) | A | 56,850 | $0.00 | 56,850 | D | A |
| 13 Mar, 2026 | Joseph R Young | Class A Common Stock | A | 10,000 | $3.94 | 75,754 | D | M |
| 13 Mar, 2026 | Joseph R Young | Class A Common Stock | A | 10,000 | $3.94 | 75,754 | D | M |
| 13 Mar, 2026 | Joseph R Young | Stock Option (right to buy) | D | 10,000 | $0.00 | 38,589 | D | M |
| 13 Mar, 2026 | Joseph R Young | Stock Option (right to buy) | D | 10,000 | $0.00 | 38,589 | D | M |
| 05 Mar, 2026 | Christopher Hite | Stock Option (right to buy) | A | 24,937 | $0.00 | 24,937 | D | A |
| 23 Feb, 2026 | Joseph R Young | Class A Common Stock | D | 3,117 | $41.98 | 64,722 | D | S |
| 23 Feb, 2026 | Robert Brenner | Class A Common Stock | D | 2,151 | $41.98 | 50,947 | D | S |
| 23 Feb, 2026 | William D. Turner | Class A Common Stock | D | 2,187 | $41.98 | 45,313 | D | S |
| 23 Feb, 2026 | Sean Grant | Class A Common Stock | D | 4,949 | $41.98 | 114,181 | D | S |
| 23 Feb, 2026 | David Lee Johnson | Class A Common Stock | D | 2,579 | $41.98 | 45,727 | D | S |
| 23 Feb, 2026 | Laurence Matthew Skelton | Class A Common Stock | D | 1,582 | $41.98 | 64,218 | D | S |
| 23 Feb, 2026 | Joseph R Young | Class A Common Stock | D | 3,117 | $41.98 | 64,722 | D | S |
| 23 Feb, 2026 | Marshall Fordyce | Class A Common Stock | D | 16,925 | $41.98 | 257,163 | D | S |